Since oncogenic mutations in KRAS are predominantly found in human lung, pancreatic and colorectal tumors, it would be intriguing to assess whether KRAS4A and 4B would display a differential carcinogenic potential in those tissues as well. Here, KRAS is linked to colorectal neoplasm.